These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 436304)

  • 41. Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
    Sang GW; Liu XH
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):255-9. PubMed ID: 2954375
    [No Abstract]   [Full Text] [Related]  

  • 42. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics of norethindrone-3-oxime and norethindrone in rhesus monkeys].
    Fu GM; Zuo MD; Li DZ; Zhou MY; Zhao XL; Wang GP; Wei ZN; Wang XL; Li ZX
    Yao Xue Xue Bao; 1991; 26(1):1-5. PubMed ID: 1887788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rabbit as an animal model to study pharmacokinetics of norethindrone in women.
    Prasad KV; Sivakumar B; Narasinga Rao BS
    Contraception; 1979 Dec; 20(6):619-32. PubMed ID: 119608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of norethisterone from two different combination contraceptive pills in Indian women.
    Sivakumar B; Prasad KV; Ravinder P; Ramalakshmi BA; Narasinga Rao BS
    Indian J Physiol Pharmacol; 1989; 33(1):10-4. PubMed ID: 2737742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of norethindrone: effect of particle size.
    Saperstein S; Edgren RA; Jung D; Mroszczak EJ; Lee GJ; Dorr A; Pritchard R; Kushinsky S; Fong JC; Combs DL
    Contraception; 1989 Dec; 40(6):731-40. PubMed ID: 2620531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ovarian changes after long-term oral contraception.
    Plate WP
    Acta Endocrinol (Copenh); 1967 May; 55(1):71-7. PubMed ID: 6071598
    [No Abstract]   [Full Text] [Related]  

  • 48. Formation of ethinyl estradiol in women during treatment with norethindrone acetate.
    Chu MC; Zhang X; Gentzschein E; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2205-7. PubMed ID: 17341557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
    Victor A; Lithell H; Selinus I; Vessby B
    Ups J Med Sci; 1984; 89(2):179-88. PubMed ID: 6380076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
    Yu Z; Yu D; Walker PS; Tang-Liu DD
    Clin Pharmacokinet; 2004; 43(10):673-84. PubMed ID: 15244497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of norethisterone following its oral administration and by spraying it nasally or sublingually to male bonnet monkeys.
    Puri CP; Vajifdar BS; Nayak VG; Dhanasekaran K; Pongubala JM; Hamied YK; Anand Kumar TC
    Contraception; 1987 Apr; 35(4):381-8. PubMed ID: 3621938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic influence of oral contraceptives.
    Anberg A
    Acta Obstet Gynecol Scand; 1966; 45(S9):40. PubMed ID: 5958395
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Return of ovulation after discontinuance of oral contraceptives.
    Rice-Wray E; Correu S; Gorodovsky J; Esquivel J; Goldzieher JW
    Fertil Steril; 1967; 18(2):212-8. PubMed ID: 6020669
    [No Abstract]   [Full Text] [Related]  

  • 55. First-pass effect of norethindrone in rabbits and rats.
    Back DJ; Breckenridge AM; Crawford FE; Orme ML; Rowe PH; Smith E
    J Pharmacol Exp Ther; 1978 Nov; 207(2):555-65. PubMed ID: 712638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Existence of multiple peaks in plasma ethinyl estradiol and norethindrone after oral administration of a contraceptive pill.
    Zacur HA; Burkman RT; Kimball AW; Kwiterovich P; Bell WR
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1268-72. PubMed ID: 1430087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma levels of norethidrone in Indian women receiving norethidrone enanthate (20 mg) injectable.
    Prasad KV; Nair KM; Sivakumar B; Prema K; Rao BS
    Contraception; 1981 May; 23(5):497-506. PubMed ID: 7285573
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Norethisterone and ethinyl estradiol kinetics during dapsone therapy.
    Joshi JV; Maitra A; Sankolli G; Bhatki S; Joshi UM
    J Assoc Physicians India; 1984 Feb; 32(2):191-3. PubMed ID: 6746515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.